Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Case Management for Crack Users Who Seek Treatment in CAPSad in Brazil

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2012 by Federal University of Rio Grande do Sul.
Recruitment status was  Recruiting
Sponsor:
Collaborators:
Hospital de Clinicas de Porto Alegre
Brazilian Secretariat for Drug Policies (SENAD)
Federal University of Bahia
Federal University of Espirito Santo
Universidade Federal do Rio de Janeiro
Faculdade de Medicina do ABC
University of Brasilia
Information provided by (Responsible Party):
Professor Flavio Pechansky, Federal University of Rio Grande do Sul
ClinicalTrials.gov Identifier:
NCT01558726
First received: March 17, 2012
Last updated: NA
Last verified: March 2012
History: No changes posted

March 17, 2012
March 17, 2012
October 2011
August 2012   (final data collection date for primary outcome measure)
Treatment retention [ Time Frame: 3 months ] [ Designated as safety issue: No ]
Same as current
No Changes Posted
  • Crack abstinence [ Time Frame: 3 months ] [ Designated as safety issue: No ]
  • ASI subareas scores [ Time Frame: 3 months ] [ Designated as safety issue: No ]
    ASI (Addiction Severity Index)
Same as current
Not Provided
Not Provided
 
Case Management for Crack Users Who Seek Treatment in CAPSad in Brazil
Effectiveness of Case Management for Crack Users Who Seek Treatment in CAPSad in Six Brazilian Capitals

The purpose of this study is to evaluate the effectiveness of a Case Management (CM) intervention in crack users applied in Psychosocial Care Centers - Alcohol and Drugs (CAPSad) by trained social workers, in comparison to CAPSad conventional treatment on 30 and 90 days, considering the following outcomes: treatment retention, abstinence and changes in severity scores of the sixth version of Addiction Severity Index (ASI6) scale. The study hypothesis are: 1) The CM is going to improve the retention of crack users (cases) during the 3-month follow-up compared with usual care (controls); 2)Individuals who received the intervention with GC are going to present a higher rate of abstinence; 3)The summary scores of the ASI6 will be significantly lower in cases than in controls, at the end of 3 months follow-up.

Not Provided
Interventional
Not Provided
Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Treatment
Crack Abuse or Dependence
  • Behavioral: Case Management (Strength-Based)
    To improve the cases sharing between CAPSad and other health institutions and individuals and increase the strengths of the patient to cope with problems related to the crack use.
  • Behavioral: Usual Treatment
    The usual treatment used for regular patients of CAPSad
  • Experimental: Case management
    Intervention: Behavioral: Case Management (Strength-Based)
  • Active Comparator: Usual treatment
    Usual treatment of the CAPSad
    Intervention: Behavioral: Usual Treatment
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
600
August 2012
August 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Diagnosis of crack abuse or dependence
  • > 18 years old
  • Initiating treatment (maximum of 1 month)

Exclusion Criteria:

  • Homeless without permanent contact
  • Psychotic symptoms during the intake interview
Both
18 Years and older
No
Contact: Flavio Pechansky, PhD 55-51-3359-7480 fpechans@uol.com.br
Contact: Felix HP Kessler, PhD
Brazil
 
NCT01558726
10-0176
No
Professor Flavio Pechansky, Federal University of Rio Grande do Sul
Federal University of Rio Grande do Sul
  • Hospital de Clinicas de Porto Alegre
  • Brazilian Secretariat for Drug Policies (SENAD)
  • Federal University of Bahia
  • Federal University of Espirito Santo
  • Universidade Federal do Rio de Janeiro
  • Faculdade de Medicina do ABC
  • University of Brasilia
Principal Investigator: Flavio Pechansky, PhD Center for Drug and Alcohol Research (CPAD) of Federal University of Rio Grande do Sul
Federal University of Rio Grande do Sul
March 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP